Literature DB >> 15157846

The telltale scan: APOE epsilon4 in multiple sclerosis.

Thomas Masterman1, Jan Hillert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157846     DOI: 10.1016/S1474-4422(04)00763-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

1.  Alteration of DBP levels in CSF of patients with MS by proteomics analysis.

Authors:  Zhaoyu Qin; Yanjiang Qin; Shilian Liu
Journal:  Cell Mol Neurobiol       Date:  2008-09-19       Impact factor: 5.046

Review 2.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.

Authors:  Guojun Bu
Journal:  Nat Rev Neurosci       Date:  2009-04-02       Impact factor: 34.870

3.  Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months.

Authors:  Athina Pappas; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef C Cortez; Gaurav Bhatti; Nardhy Gomez-Lopez; Sonia S Hassan; Seetha Shankaran; Adi L Tarca
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

4.  A rapid and cost-effective method for genotyping apolipoprotein E gene polymorphism.

Authors:  Li Zhong; Yong-Zhuang Xie; Tian-Tian Cao; Zongqi Wang; Tingting Wang; Xinxiu Li; Rui-Chi Shen; Huaxi Xu; Guojun Bu; Xiao-Fen Chen
Journal:  Mol Neurodegener       Date:  2016-01-12       Impact factor: 14.195

5.  ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study.

Authors:  Farshid Mashayekhi; Saeed Sadigh-Eteghad; Amirreza Naseri; Milad Asadi; Negin Abbasi Garravnd; Mahnaz Talebi
Journal:  Neurol Sci       Date:  2021-06-12       Impact factor: 3.307

Review 6.  Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.

Authors:  Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.